DERMAPHARM HLDG SE NPVDERMAPHARM HLDG SE NPVDERMAPHARM HLDG SE NPV

DERMAPHARM HLDG SE NPV

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪1.70 B‬EUR
‪62.37 M‬EUR
‪1.14 B‬EUR
‪17.17 M‬
Beta (1Y)
0.52

About DERMAPHARM HLDG SE NPV

CEO
Hans-Georg Feldmeier
Headquarters
Grunwald
Founded
2017
ISIN
DE000A2GS5D8
FIGI
BBG00XX75660
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company operates through the Branded pharmaceuticals and other healthcare products, Parallel import business and Herbal extracts divisions. Its products include covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0A5J is 31.10 EUR — it has decreased by 0.96% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange DERMAPHARM HLDG SE NPV stocks are traded under the ticker 0A5J.
DERMAPHARM HLDG SE NPV is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
0A5J stock is 0.96% volatile and has beta coefficient of 0.52. Check out the list of the most volatile stocks — is DERMAPHARM HLDG SE NPV there?
0A5J earnings for the last quarter are 0.27 EUR per share, whereas the estimation was 0.72 EUR resulting in a −62.50% surprise. The estimated earnings for the next quarter are 0.95 EUR per share. See more details about DERMAPHARM HLDG SE NPV earnings.
DERMAPHARM HLDG SE NPV revenue for the last quarter amounts to ‪319.10 M‬ EUR despite the estimated figure of ‪309.00 M‬ EUR. In the next quarter revenue is expected to reach ‪262.90 M‬ EUR.
Yes, you can track DERMAPHARM HLDG SE NPV financials in yearly and quarterly reports right on TradingView.
0A5J stock has fallen by 1.43% compared to the previous week, the month change is a 6.72% fall, over the last year DERMAPHARM HLDG SE NPV has showed a 31.32% decrease.
0A5J net income for the last quarter is ‪−2.69 M‬ EUR, while the quarter before that showed ‪24.84 M‬ EUR of net income which accounts for −110.84% change. Track more DERMAPHARM HLDG SE NPV financial stats to get the full picture.
Yes, 0A5J dividends are paid annually. The last dividend per share was 1.05 EUR. As of today, Dividend Yield (TTM)% is 3.38%. Tracking DERMAPHARM HLDG SE NPV dividends might help you take more informed decisions.
Like other stocks, 0A5J shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DERMAPHARM HLDG SE NPV stock right from TradingView charts — choose your broker and connect to your account.
0A5J reached its all-time high on Nov 4, 2021 with the price of 91.25 EUR, and its all-time low was 31.20 EUR and was reached on Apr 18, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DERMAPHARM HLDG SE NPV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DERMAPHARM HLDG SE NPV stock shows the sell signal. See more of DERMAPHARM HLDG SE NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DERMAPHARM HLDG SE NPV future price: according to them, 0A5J price has a max estimate of 58.00 EUR and a min estimate of 41.50 EUR. Read a more detailed DERMAPHARM HLDG SE NPV forecast: see what analysts think of DERMAPHARM HLDG SE NPV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DERMAPHARM HLDG SE NPV EBITDA is ‪317.38 M‬ EUR, and current EBITDA margin is 26.86%. See more stats in DERMAPHARM HLDG SE NPV financial statements.